Kruze D, Biro K, Holzbecher K, Andrial M, Bossart W
Microbiology Department, Solco Basle Ltd., Switzerland.
Urol Res. 1992;20(2):177-81. doi: 10.1007/BF00296534.
The protective effect of immunization with a polyvalent vaccine (SolcoUrovac) was studied in the mouse and the rat. The i.m. immunization increased the resistance of mice to challenge infection with all homologous strains of bacteria. The LD50 values for E. coli, Proteus mirabilis and Streptococcus were 3.5-4.5 times and that of Klebsiella as much as 600 times that in nonimmunized mice. Protection against challenge with heterologous E. coli was also achieved and persisted for about 20 weeks. Immunization with the vaccine also provided marked protection against pyelonephritis in rats. Kidneys with abscesses were seen only one-third as often as in controls, and the size of the individual abscesses was substantially smaller in the vaccinated animals. Based on the quantity of bacteria in the kidneys it was postulated that the vaccination increased the clearance of bacteria.
在小鼠和大鼠中研究了多价疫苗(SolcoUrovac)免疫的保护作用。肌肉注射免疫增强了小鼠对所有同源细菌菌株攻击感染的抵抗力。大肠杆菌、奇异变形杆菌和链球菌的半数致死量(LD50)值是未免疫小鼠的3.5 - 4.5倍,肺炎克雷伯菌的LD50值高达未免疫小鼠的600倍。对异源大肠杆菌攻击的保护作用也得以实现,并持续约20周。用该疫苗免疫还为大鼠提供了针对肾盂肾炎的显著保护。出现脓肿的肾脏数量仅为对照组的三分之一,且接种疫苗动物中单个脓肿的大小明显更小。根据肾脏中的细菌数量推测,接种疫苗增加了细菌清除率。